FDA officials directed to strictly implement safety measures at under-construction buildings

FAISALABAD, Jul 27 (APP): Faisalabad Development Authority (FDA) Director General Muhammad Asif Chaudhry on Monday directed that special safety measures be strictly implemented at under-construction buildings located in FDA-controlled residential colonies and commercial markets during the ongoing monsoon season.

He was chairing a meeting to review matters pertaining to under-construction buildings in view of the monsoon season. The meeting was attended by Directors Asma Mohsin, Junaid Hassan Manj, Suhail Maqsood Pannu, Afnan Saeed Sindhu, and other officers.

He particularly instructed that excavation work should be halted immediately at construction sites involving basement development whenever there was a risk of heavy rainfall.

He directed Area Inspectors to maintain strict monitoring and ensure that all safety arrangements were fully implemented to prevent any untoward incidents.

He sensitized the owners of under-construction buildings, builders, consultants, architects, structural engineers, and supervising engineers that appropriate shoring and support systems must be used during deep excavation to stabilize the surrounding soil.

He further instructed that protective fencing and clearly visible warning signs must be installed, while all necessary technical measures should be adopted to safeguard nearby buildings and infrastructure during excavation.

He stressed that all construction activities must strictly comply with safety regulations and ensure the protection of human life and property.

He further said that unauthorized persons, particularly children should be kept away from construction sites, the use of personal protective equipment (PPE) must be ensured and the relevant authorities should be contacted immediately in the event of any emergency.

The FDA Director General warned that failure to comply with the building bye-laws and government directives could result in criminal proceeding against the responsible persons, sealing of the property, cancellation of the approved building plan and the imposition of

heavy fines by the FDA.

He also appealed to the public to immediately inform the FDA if they observe inadequate safety arrangements at any under-construction building or identify any threat to human life so that timely action could be taken.